Latest Mammary ductal carcinoma Stories
REDWOOD CITY, Calif., Jan. 12 /PRNewswire-FirstCall/ -- Genomic Health, Inc.
In a new study published in the January issue of Radiology, 42 percent of women eligible for breast cancer screening with MRI declined to undergo the procedure.
Largest study of its kind reveals blacks less likely than whites to receive standard of care.
In era of minimalist therapy, some mucinous carcinoma patients may need more, not less treatment.
SAN ANTONIO, Dec. 11 /PRNewswire-FirstCall/ -- Genomic Health, Inc.
CHICAGO, Nov. 30 /PRNewswire/ -- Breast-Specific Gamma Imaging (BSGI) has been proven to be a highly sensitive imaging technique for the detection of ductal carcinoma in situ (DCIS), a difficult to diagnose breast cancer.
SEATTLE, Nov. 25 /PRNewswire/ -- Mammography Reporting System, Inc. (MRS) will demonstrate their newest high risk indicator at RSNA 2009, in Chicago.
Study finds higher risk of cancer recurrence in women with dense breasts.
The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer.